PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Retained Earnings
-$3.5B
CAGR 3-Years
-24%
CAGR 5-Years
-27%
CAGR 10-Years
-25%
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$11.2B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.1B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$7.6B
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$29.4B
CAGR 3-Years
25%
CAGR 5-Years
38%
CAGR 10-Years
84%

See Also

What is PTC Therapeutics Inc's Retained Earnings?
Retained Earnings
-3.5B USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Retained Earnings amounts to -3.5B USD.

What is PTC Therapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-25%

Over the last year, the Retained Earnings growth was -16%. The average annual Retained Earnings growth rates for PTC Therapeutics Inc have been -24% over the past three years , -27% over the past five years , and -25% over the past ten years .

Back to Top